维生素D强化:在治疗干预中克服耐药性和耐受性的一种有前途的方法。

IF 2.3 Q2 BIOLOGY
Scientifica Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI:10.1155/2024/9978076
Digvijaya, Saurabh Mittal, Prateek Mittal, Ruhi Singh, Simran Gupta, Taniya Singh, Rahmuddin Khan, Nafaa Alzobaidi, Abdulsalam Alhalmi
{"title":"维生素D强化:在治疗干预中克服耐药性和耐受性的一种有前途的方法。","authors":"Digvijaya, Saurabh Mittal, Prateek Mittal, Ruhi Singh, Simran Gupta, Taniya Singh, Rahmuddin Khan, Nafaa Alzobaidi, Abdulsalam Alhalmi","doi":"10.1155/2024/9978076","DOIUrl":null,"url":null,"abstract":"<p><p>The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT01169259 and NCT04342598.</p>","PeriodicalId":21726,"journal":{"name":"Scientifica","volume":"2024 ","pages":"9978076"},"PeriodicalIF":2.3000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606658/pdf/","citationCount":"0","resultStr":"{\"title\":\"Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions.\",\"authors\":\"Digvijaya, Saurabh Mittal, Prateek Mittal, Ruhi Singh, Simran Gupta, Taniya Singh, Rahmuddin Khan, Nafaa Alzobaidi, Abdulsalam Alhalmi\",\"doi\":\"10.1155/2024/9978076\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT01169259 and NCT04342598.</p>\",\"PeriodicalId\":21726,\"journal\":{\"name\":\"Scientifica\",\"volume\":\"2024 \",\"pages\":\"9978076\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606658/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scientifica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2024/9978076\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scientifica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/9978076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

耐药性和耐受性的问题是一个重大的挑战,因为它降低了药物的疗效和效力,对全世界努力提高药物治疗的医生构成了一个巨大的障碍。这些抗性机制可能来自遗传易感性或作为医疗干预的结果。值得注意的是,获得性耐药或耐受性可能扩展到同一或不同类别的其他药物,尽管其作用机制不同。随着时间的推移,这种现象导致各种药物治疗无效,阻碍了许多疾病的完全缓解,包括代谢紊乱、自身免疫性疾病、癌症、传染病、心血管疾病和神经系统疾病。维生素D是一种重要的脂溶性营养素,对调节钙和磷水平至关重要,它正在成为一种潜在的解决方案,可以抵消癌症、结核病和抑郁症等各种疾病的治疗耐药性和耐受性。这篇综述仔细审查了现有的研究,并为未来的研究提供了见解,旨在充分阐明维生素D在减轻长期用药方案和药物治疗失败带来的挑战方面的治疗潜力。试验注册:ClinicalTrials.gov标识符:NCT01169259和NCT04342598。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions.

The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures. Trial Registration: ClinicalTrials.gov identifier: NCT01169259 and NCT04342598.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Scientifica
Scientifica BIOLOGY-
CiteScore
6.70
自引率
0.00%
发文量
43
审稿时长
21 weeks
期刊介绍: Scientifica is a peer-reviewed, Open Access journal that publishes research articles, review articles, and clinical studies covering a wide range of subjects in the life sciences, environmental sciences, health sciences, and medicine. The journal is divided into the 65 subject areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信